Completed NA INTERVENTIONAL 3-arm NCT01786811

Serious Illness Communication Project

Sponsor: Brigham and Women's Hospital

Interventions Training

Updated 8 times since 2017 Last updated: Jan 17, 2019 Started: Jun 30, 2012 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01786811, this NA trial focuses on Cancer and End of Life Care and remains completed. Sponsored by Brigham and Women's Hospital, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jan 2022 [monthly]

Completed NA
Feb 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed NA
Jun 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2017 — Jun 2017 [monthly]

Active Not Recruiting NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital
Charina Endowment Fund
Dana-Farber Cancer Institute
Harvard School of Public Health (HSPH)
Margaret T. Morris Foundation
Partners HealthCare

Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States